AIHCC
Index Performance
+1.84%
AIHCC
-6.55%
IBB
Overview
Description
The Intelligent Healthcare Conviction strategy (AIHC) uses OpenAI's ChatGPT, Google's Bard, and Inflection AI's Claude to build an equal weighted portfolio of the committee's highest conviction US-listed stocks in the healthcare sector. The strategy aims to create superior quality-focused returns compared to the MSCI US Investable Market Health Care 25/50 Index.
- TickerAIHCC
- Inception Date10/16/2023
- WeightingEqual
- # of holdings30
What's inside?
Holdings
All holdings as of April 29, 2024
CSV download
| Shockwave Medical, Inc. (SWAV) | 4.04% | $12.36B | 49.11% | 86.94% | 9.67 |
| AstraZeneca PLC (AZN) | 3.87% | $233.35B | 11.68% | 75.21% | 4.95 |
| ResMed, Inc. (RMD) | 3.84% | $31.91B | 7.17% | 56.94% | 6.57 |
| Boston Scientific Corp. (BSX) | 3.67% | $106.57B | 13.78% | 68.65% | N/A |
| Merck & Co., Inc. (MRK) | 3.62% | $329.55B | 8.15% | 81.23% | N/A |
| Elevance Health, Inc. (ELV) | 3.50% | $124.11B | 0.96% | N/A | 0.86 |
| Amgen, Inc. (AMGN) | 3.45% | $148.12B | 7.35% | 69.96% | 7.48 |
| Insulet Corp. (PODD) | 3.45% | $11.92B | 30.02% | 68.84% | 9.85 |
| Hologic, Inc. (HOLX) | 3.39% | $17.99B | -5.69% | 54.70% | 4.49 |
| UnitedHealth Group, Inc. (UNH) | 3.35% | $449.95B | 8.56% | N/A | 1.41 |
| GE Healthcare Technologies, Inc. (GEHC) | 3.34% | $40.50B | 6.60% | 40.69% | 2.20 |
| Danaher Corp. (DHR) | 3.33% | $182.82B | -19.13% | 60.16% | 7.59 |
| Becton, Dickinson & Co. (BDX) | 3.32% | $67.44B | 2.62% | 43.07% | 4.41 |
| Thermo Fisher Scientific, Inc. (TMO) | 3.32% | $220.21B | -3.41% | 36.29% | 5.92 |
| Biogen, Inc. (BIIB) | 3.30% | $31.38B | -5.62% | 68.65% | 4.02 |
| Eli Lilly & Co. (LLY) | 3.28% | $700.90B | 19.56% | 79.25% | 16.09 |
| Medtronic Plc (MDT) | 3.28% | $107.37B | 4.68% | 60.33% | 4.09 |
| Zimmer Biomet Holdings, Inc. (ZBH) | 3.26% | $24.96B | 6.55% | 63.06% | 4.21 |
| Vertex Pharmaceuticals, Inc. (VRTX) | 3.26% | $102.34B | 12.47% | 87.17% | 9.71 |
| DexCom, Inc. (DXCM) | 3.24% | $50.03B | 24.21% | 61.01% | 15.12 |
| Stryker Corp. (SYK) | 3.23% | $128.86B | 11.11% | 60.95% | 6.11 |
| IDEXX Laboratories, Inc. (IDXX) | 3.20% | $41.99B | 8.72% | 59.72% | 12.90 |
| Intuitive Surgical, Inc. (ISRG) | 3.17% | $132.71B | 11.46% | 65.87% | 19.01 |
| Edwards Lifesciences Corp. (EW) | 3.12% | $51.68B | 9.50% | 75.96% | 9.25 |
| Johnson & Johnson (JNJ) | 3.12% | $353.80B | -13.55% | 74.59% | N/A |
| Pfizer Inc. (PFE) | 3.08% | $144.78B | -41.70% | 50.06% | 3.88 |
| Penumbra, Inc. (PEN) | 3.05% | $7.83B | 24.95% | 63.55% | 9.27 |
| AbbVie, Inc. (ABBV) | 3.05% | $285.99B | 0.70% | 82.75% | N/A |
| Gilead Sciences, Inc. (GILD) | 3.03% | $82.23B | 5.66% | 76.79% | N/A |
| Bristol Myers Squibb Co. (BMY) | 2.86% | $90.49B | 4.66% | 55.54% | 3.46 |
Market data by FactSet